Andrew Kuykendall is an Associate Member in the Malignant Hematology Department at H. Lee Moffitt Cancer Center & Research Institute and an Assistant Professor in the Department of Oncologic Sciences at the University of South Florida (USF).
Currently, Dr. Kuykendall leads the myeloproliferative neoplasm program at Moffitt Cancer Center, where he focuses his clinical and research efforts on patients with essential thrombocythemia, polycythemia vera, myelofibrosis and systemic mastocytosis. Through retrospective, translational, and collaborative research he is focused on better defining these heterogeneous diseases and developing disease-modifying therapies for patients with MPNs.